Texas HIV Medication Program

Apply | Questions? | Contact Us

The Texas HIV Medication Program (THMP) provides medications for the treatment of HIV and its related complications for low-income Texans. To qualify for medications, potential clients who meet eligibility criteria complete an application for assistance. Once approved, a client receives medications at an assigned pharmacy in their community.

To learn more about the THMP and find out if you are eligible, see the Frequently Asked Questions. You can apply for the program by visiting TakeChargeTexas (TCT) or downloading and completing the client application. Be sure and review the specific “application instructions” when completing the application. The application and its instructions are located on the THMP document page. If you have more questions or need assistance completing your application, call the THMP toll-free at 800-255-1090.

The THMP is the official AIDS Drug Assistance Program (ADAP) for the State of Texas. The THMP started in 1987 and provides medications approved by the Food and Drug Administration (FDA) for the treatment of illnesses caused by HIV and other opportunistic infections in people living with HIV as prescribed by their doctor. THMP also operates the Texas HIV State Pharmaceutical Assistance Program (SPAP), which helps people living with HIV who do not qualify for the full Low-Income Subsidy (extra help) with their out-of-pocket costs associated with Medicare Part D prescription drug plans, including co-payments, deductibles, coinsurance, and during the coverage gap (the "donut hole").

THMP Email List

Sign up to one or more email lists below today to receive timely and relevant news from THMP:

Subscribe to THMP News – News about significant events for the THMP program.

Subscribe to THMP Participating Pharmacies – Updates of interest to THMP participating pharmacies.

Subscribe to THMP Eligibility – Information for ADAP Enrollment Workers (AEW) and others who assist clients in THMP application submission and their supervisors.

THMP to Offer Insurance Assistance Services Starting in January 2025

The Texas HIV Medication Program (THMP) will begin providing insurance assistance services for people living with HIV who are eligible for the AIDS Drug Assistance Program (ADAP). For more information, please visit the THMP ADAP eligibility requirements page.

ADAP will pay for premiums and prescription drug copayments for eligible health insurance plans starting in January 2025. THMP will enroll clients in insurance plans, including plans on the federal Health Insurance Marketplace (Affordable Care Act plans), during the upcoming open enrollment period from November 1, 2024, through January 15, 2025. More information is coming soon on how clients can enroll. THMP encourages you to subscribe to the THMP News to stay updated.

THMP looks forward to working with stakeholders and clients on this important new service.

Register for the TakeChargeTexas (TCT) Pharmacy Portal

The TakeChargeTexas (TCT) Pharmacy Portal rollout is now available.

Participating pharmacies must complete the Data Security and Confidentiality course as detailed in the Security and Confidentiality Training, Security and Confidentiality Course Instructions before registering for TCT access in the Enterprise Portal. Once completed, pharmacies email a copy of the certificate to TBHIVSTD.AccountRequests@dshs.texas.gov.

Training is available on the TCT website.

Pharmacies can request TCT access at iamonline.hhs.state.tx.us. The IAMOnline Transition Guide contains instructions to register as a pharmacy.

Please email medication@dshs.texas.gov if you have any questions about this notification, or email the TCT Help Desk at TCTHelpDesk@dshs.texas.gov for assistance with technical issues.

Attention TCT Users: IAMOnline Replaced the Enterprise Portal

What is IAMOnline?

IAMOnline is the new HHS Identity Management Solution, replacing the HHS Enterprise Portal. It includes a simplified log-in experience with single sign-on (SSO) and streamlined access management processes.

Why do you need to know?

HHS discontinued the HHS Enterprise Portal. TCT transitioned to a new portal, IAMOnline, for access management. All TCT users, including third-party vendors, partners, providers, and non-HHS staff, must have an IAMOnline account to access TCT.

The way you log into TCT did not change. The only thing that did change is that the system directs you to IAMOnline when changing your password.

Existing external client portal users:

• Login through the Client Portal Public Website.
• Log into the TCT client portal website using your existing TCT username and password.
• If you forgot your password, click the Forgot Password link to go to the IAMOnline website to change your password.
• New client users will click Register and Apply on the Citizen User Portal to create a new account.

If you need further assistance, please email tcthelpdesk@dshs.texas.gov.

THMP Notification Regarding Standard Deduction

The Texas Department of State Health Services (DSHS) has an important notification for participants of the Texas HIV Medication Program (THMP). Please review the information provided and contact us at 1-800-255-1090 or hivstd@dshs.texas.gov if you have any questions. Please do not include personal identifying information about a THMP applicant or participant via email.

THMP uses a standard deduction to adjust the household income for applicants, new applicants and recertifications, for eligibility purposes. THMP recalculates the standard deduction amount each year. The annual standard deduction amount for April 16, 2024, to March 31, 2025 is $11,177, which is a decrease from the previous year's amount of $12,240.

To calculate the annualized average per-client expenditure, THMP uses the previous state fiscal year's expended amount to determine the average amount spent on each client, which is then annualized on a per-client basis to determine the standard deduction.

Existing program participants will have their income eligibility reviewed at the next scheduled program recertification. Participants are required to submit recertification applications by the last day of their birth month, and their eligibility will be based on their income at the time of recertification.

Case managers should update impacted clients.

Formulary Addition

A medication has been added to the THMP Formulary as a 90-day option:

• Delstrigo-90 Day (doravirine/lamivudine/tenofovir), 100/300/300 mg tablets, #30 per bottle (to be ordered for 3 bottles)

The Medical Certification Form and THMP Formulary have been updated. Both can be found on the THMP documents page.

Texas HIV Medication Program Notifications

DSHS has three important notifications for clients participating in THMP. Please review the information provided and contact us at 1-800-255-1090 or hivstd@dshs.texas.gov if you have any questions.

THMP began using a new method to determine eligibility for the program in 2023. The new method created a more equitable and transparent eligibility process.

Previously, THMP determined financial eligibility by subtracting personal HIV drug costs from a person’s income. Beginning in 2023, THMP determined financial eligibility by subtracting $12,240 from a person’s income. This standard deduction is the average drug cost per THMP client. Each year, THMP will adopt a new standard deduction amount of the average client drug cost.

THMP uses the standard deduction to determine your eligibility during your annual recertification period. If your recertification period was after April 1, 2023, your eligibility remained the same until your next annual recertification. At that time, THMP used the new method to determine your eligibility.

You should contact your case worker to understand how this change will affect you.

Second, THMP reinstated the ten medications below, effective April 1, 2023.

These medications are available to new and existing enrollees. Existing participants received a letter by March 1, 2023, informing them that these medications were available.

Please share this information with those you know this change may impact.

Third, if you are a current Take Charge Texas (TCT) user and would like to provide feedback on future enhancements, contact THMP at hivstd@dshs.texas.gov and include “TCT Feedback” in the subject line.

THMP will invite those who email to see demonstrations of future system enhancements and give you the opportunity to provide feedback upon viewing the demonstration.

New Dosages of Three Medications Used To Treat HIV in Infants and Children Have Been Approved for Addition to the THMP Formulary

New dosages of three medications used to treat HIV in infants and children have been approved by the Department of State Health Services (DSHS) Commissioner of Health in addition to the Texas HIV Medication Program (THMP) AIDS Drug Assistance Program (ADAP) Formulary:

• Tivicay PD (dolutegravir) 25 mg
• Isentress (raltegravir) 25 mg
• low-dose Biktarvy (bictegravir 30 mg/emtricitabine 120 mg/tenofovir alafenamide 15 mg)

DSHS was able to estimate the fiscal impact of this change with reasonable certainty based on current data related to pediatric client loads and medication usage. The estimated fiscal impact of this change is minimal, with the possibility of a resulting positive fiscal impact when compared with maintaining only the current pediatric options. Consequently, DSHS is able to support these additions within existing monies and has approved adding these pediatric medications to the formulary.

THMP updated its formulary.

Please submit a new THMP Medical Certification Form (MCF) for any infants and children in need of these new medication doses.

Thanks to the Medication Advisory Committee for recommending these changes.